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j Summary: Reliability of test results, convenient handling and flexibility are major requirements on automated
! immunoassays systems. To investigate to what extent these requirements were met by the Pharmacia CAP and DPC
IMMULITE and DPC Microplate Systems, we evaluated several performance characteristics of assays of specific
IgE against some common inhalant allergens as well as the atopy tests Phadiatop (Pharmacia CAP System) and
AlaTOP (DPC IMMULITE and Microplate System).
Comparing Phadiatop and AlaTOP results (n = 95) to clinical data, the sensitivity was found to be 97% in the
Pharmacia CAP System and 82% in the AlaTOP-DPC Microplate System and 88% with AlaTOP-IMMULITE.
Specificity was in all cases higher than 90%.
The pooled total variation was more than twice as high with the DPC Microplate System as compared to the
Pharmacia CAP System in our first investigation. A second investigation showed similar values.
The investigation of systematic differences showed that the error contribution of sample related differences between
the systems was even larger and far exceeded the analytical variation. Thus the two methods do not seem to be
measuring the same specific IgE antibodies. In 8 out of 8 cases with the Pharmacia CAP System positive and DPC
negative results and in 2 out of 2 cases with DPC positive and Pharmacia CAP System negative results, the presence
of IgE antibodies could be confirmed by IgE immunoblotting. Serum dilutions showed very irregular O/E patterns
for the DPC Microplate System.
There was no effect wheri adding non-specific IgE to serum samples. Addition of competing IgG antibodies showed
a moderate decrease in binding of specific IgE in the Pharmacia CAP System when increasing amounts of IgG
were added. The effect in the DPC Microplate System was more pronounced with large decreases, or increases of
measured values even at lower concentration of the competing antibody. The results may indicate insufficient
allergen concentration in the DPC assay and draw attention to the risk for undesirable complex formation between
allergen and antibody in solution.
The combination of the two DPC systems did not offer any advantages over Pharmacia CAP System from the
handling or work flow point of view.
Introduction eludes the test AlaTOP allows random access allergy
Automated systems in our laboratories are expected to screening testinS and would reduce Pre 3η3ΐ^ίθ31 work
be easy to handle and as flexible as possible to enable lme'
laboratory personnel to work with them at all times. The AlaTOP IMMULITE and follow up with allergen spe-
recently introduced IMMULITE (DPC) (1,2) which in- cific IgE tests on a DPC Microplate automated micro-
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plate system (DPC) could be an alternative to the Phar-
macia CAP System presently used in one of our
laboratories for differential as well as specific allergy
testing in the following configuration: RoboCAP, Auto-
CAP and FluoroCount 96. Studies performed previously
(3,4) usually compared performance to the skin prick
test (SPT). In this study we wanted to examine the per-
formance of both systems from a quantitative stand-
point.
The need for initial differential tests is indicated in sev-
eral studies (5, 6, 7). The quantitative measurement of
specific IgE antibodies has been proposed as a basis to
correlate severity of disease with serum concentration of
IgE antibodies (8, 9). This has also been expressed as a
preference by the clinicians at and around Maaslandszie-
kenhuis, Sittard. The aim of the study was to investigate
the performance characteristics of the tests run on the
combination of two DPC systems as compared to Phadi-
atop and specific IgE antibody assay on the Pharmacia
CAP System.
The following performance characteristics were eval-
uated:
— clinical sensitivity and specificity of AlaTOP in the
two DPC systems and of Phadiatop®
— within, between and total assay run precision
- systematic differences between the specific IgE as-
says
— consistency after dilution
— interference from allergen specific IgG antibodies
- influence from unspecific IgE.




The Pharmacia CAP System FEIA is a fluorescent enzyme
immunoassay. The allergens, covalently coupled to the Immuno-
CAP, react with the specific IgE in the patient serum and enzyme
labelled anti-IgE antibodies are added to form a complex. This is
incubated with a development agent. When the reaction is finished
the fluorescence is measured.
The DPC Microplate System is an enzyme immunometric assay
based on liquid ligand labelled allergens and separation by ligand-
coated wells. The specific IgE in the patient sample forms an aller-
gen-IgE complex which is incubated with a multivalent anti-ligand
which in turn links the allergen-lgE complexes and the ligand-
coated wells. Horseradish peroxidase labelled monoclonal anti-IgE
antibodies are added to the allergen-lgE complex. A chromogenic
indicator is added and the result is measured kinetically.
IMMULITE is a chemiluminescent enzyme immunoassay, based
on the same principle as Microplate but utilising an alkaline phos-
phatase-labelled anti-human IgE which reacts with a chemilumi-
nescent substrate. Anti ligand coated polystyrene beads are used to
capture the ligand labelled allergens.
WHO-IgE based calibrators are used for determination of total JgE
and values expressed in kU/1. In Pharmacia CAP System these
standards are also used for the determination of specific IgE anti-
bodies and the values are expressed in kUA/l. For study purposes
we have used kU/1 as the measuring unit for both systems. For
further details of the different test systems, see the directions for
use from the system suppliers.
Instruments and reagents






DPC instruments and reagents





















Patient, assay and instrument
management, evaluation and re-
port
Specific IgE and Phadiatop
Measurement of absorbance
Sera and reagent pipetting
Washing and incubation
Patient, assay and instrument
management, evaluation and re-
port
Specific IgE and AlaTOP
Incubation, process, reagent addi-
tion, measurement and evaluation
AlaTOP allergy screen
g6, Timothy, Phleum pratense
t3, Common silver birch, Betula
pendula
w6, Mugwort, Artemisia vulgaris
PAGE immunoblotting was per-
formed essentially as described
by Bengtsson et al. (10). The
scanning of the IgE-antibody
zones of the blot was performed
with the help of Image Master™,
Pharmacia Biotech,' Uppsala
Sweden.
Western Blot procedure was per-




The standard deviations of the error components within and be-
tween runs were estimated from analysis of variance and are pre-
sented as coefficients of variation, CY(%), i.e. the standard deviä-
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tion in per cent of the mean, As an estimate of a common CV for
all species, the pooled CV is calculated according to
CV,.,,Pooled
Ί + cvs,+ cvSs +
6
j f t + cy&
Precision experiment
Allergen specific IgG antibodies against the allergens d l , e l , e5,
go, t3 and w6 were assayed in one sample per allergen in five
replicates in each of the five runs.
Compar i son of methods
The results from the method comparison arc presented graphically
in xy-plols. Straight lines have been fitted to the xy-plots according
to the method by Passing & Bahhk (12-14). As pointed out by
Altman & Bland (15), it may be more relevant to consider the
differences or ratios between the methods and therefore ratio plots,
y/x against (x + y)/2, arc also presented. By applying the statistical
analysis suggested by Nilssou (16) the existence of sample-related
differences can be tested and their standard deviations estimated.
To facilitate the interpretation the standard deviation of the sample-
related differences is expressed in relation to the expected contribu-
tion to the scatter from the random variation within runs, i.e. by
the quotient between the two standard deviations, in this paper
denoted as the coefficients of sample-related disagreement, CSD.
This coefficient gives the relative importance between sample-re-
lated differences and the variation within runs when results from
the two methods are compared. A value of CSD > 0.75 corre-
sponds to the rule of thumb given in 1. c. (16) for rejection of the
hypothesis of no sample-related differences (with a significance
level υΓ5% or less). A CSD > 1.5 should be considered an indica-
tion of a crucial contribution to a disagreement between the meth-
ods from sample-related differences.
As relative differences are more relevant than absolute ones, the
statistical analysis is performed after logarithmic transformation of
the concentrations.
Experimental Design
E s t i m a t i o n of c l i n i ca l sens i t iv i ty and spec i f i c i ty of
AlaTOP and P h a d i a t o p
Serum samples from 100 consecutive patients with suspected al-
lergy were used to assess clinical sensitivity and clinical specificity.
34 were clinically verified as atopic and 61 as non-atopic, while
in 5 cases, clinical history and available in vivo test results were
inconclusive. The latter were excluded from the comparison. The
following alternative criteria were used for positive diagnosis of
atopy; SPT of 3+ (equal to wheal of histamine control, 10 g/1),
SPT 24- in combination with positive case history for the same
allergen, SPT 1+ or 2+ in combination with positive RAST for
the same allergen or a positive provocation test. The criteria for a
negative diagnosis of atopy was; SPT negative, SPT 1 -I- in combi-
nation with negative case history or negative RAST or negative
provocation test. Patients not fulfilling criteria for positive or nega-
tive atopy diagnosis were considered as inconclusive.
Age: Average 28 years, range 17—67 years
Sex: 60 females and 40 males
Diagnosis: 41 Bronchial asthma, 19 Seasonal rhinitis and 63
Perennial rhinitis.
The serum samples were tested with Phadiatop (Pharmacia CAP
System) and AlaTOP (IMMULJTE and DPC Microplate System).
E v a l u a t i o n and comparison of per formance
characteris t ics for measurement of spec i f i c IgE
ant ibodies
All assays were allocated to five runs consisting of two plates and
evaluated with a separate calibration curve and performed during
a five day period. All samples were coded and assayed blind.
Evaluation of systematic differences
62 patient sera per allergen (dl , el , e5, g6, 13 and w6) were se-
lected according to the results with our current routine method
(Pharmacia CAP System) and used to assess the possible concor-
dance between DPC Microplate system specific IgE Microplate
(DPC Microplate System) and RAST (Pharmacia CAP System).
Dilution experiments
Two patient sera for each of the allergens d l , cl , c5, go, t3 and
w6 were diluted and assayed in duplicate, undiluted and diluted
with negative serum to 1 :2 , 1 :4 , 1 : 8 and 1 : 1 6 . The diluent
consisted of pooled human serum from healthy controls, presenting
responses below 50% of the cut-off in both systems and a concen-
tration of total IgE of approximately 5 kU/l. AJI dilutions were
made independently from the origin sample. All assays were allo-
cated to the same run. The 100 kU/l calibrator wus also diluted and
assayed in the same way for the two systems, respectively.
Addition experiment: IgE
One negative control serum per allergen (dl, e l , e5, g6,13 and w6)
and method was spiked with myeloma IgE to total IgE levels of
approximately 1000 and 3000 (kU/l) units to test for unspecified
binding of IgE protein. All samples were assayed in duplicate in
the same run.
Addition experiment: Allergen speci c igG antibodies
Allergen specific rabbit antisera were diluted with normal rabbit
scrum to 1 :2, 1 : 4 and 1 : 8. One patient serum for each of the
allergens dl, go and t3 was mixed in equal pans with negative
human serum, normal rabbit serum, the undiluted and the three
dilutions of the anti sera, Thus a series of six samples with the
same proportion of the patient serum is obtained. One is diluted
by human negative serum and the other five contain the IgG anti-
bodies (rabbit antiserum) in the proportions 1 : 2, I : 4, I : 8, I : 16
and 0. All six samples for each allergen were assayed in duplicate
in the same run. This experiment shows relative differences in risk
for interference by non-lgE antibodies competing for the same al-
lergen and may be considered as a test of the capacity of the aller-
gen reagent.
Comparison of calibrators
The assigned values of the calibrators were checked for both sys-
tems by assaying the DPC Microplate System calibrators in dupli-
cate in the Pharmacia CAP System and vice versa.
Results and Discussion
C l i n i c a l performance of P h a d i a t o p and Ala-
TOP
The results for Phadiotop (Pharmacia CAP System) and
AlaTOP (IMMULITE and DPC Microplate System) are
Bur J din Cliem Clin Biochem 1995; 33 (No 5)
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Tab. 1 Clinical sensitivity and specificity for Phadiatop and Ala-
TOP
Diagnosis Mum- Phadia- AlaTOP AlaTOP






pos neg pos neg pos neg
33 1 30 4 28 6
4 57 0 61 4 57
97 88 82
93 100 93
given in table 1 together with estimates of clinical sensi-
tivity and specificity.
33 out of 34 sera (97%) of the atopic patients were cor-
rectly classified as positive by Phadiatop. The corre-
sponding figures for AlaTOP were 30 out 34 for IM-
MULITE and 28 out of 34 for DPC Microplate System.
Specificity varied from 93-100%. These findings corre-
late well with results reported in other studies (17-19).
A differential diagnostic test for atopy is often the first
test to be performed on a patient and is followed by
allergen specific testing in the cases considered atopic
i. e. in those cases with positive Phadiatop/AlaTOR It is
obvious that high sensitivity is essential in this situation.
• t
Technical performance of specific IgE test
systems
Precision
The random variation expressed as total CV as well as
the variation within and between runs for the DPC
Microplate System were more than twice as high as for
the Pharmacia CAP System (see tab. 2, trial 1). The ob-
tained results (kU/1) in trial 1 were also higher with the
Pharmacia CAP System than with the DPC Microplate
System, apart from go where the figure was obtained by
extrapolation by the DPC software.
In order to rule out a faulty instrument as the cause of
imprecision (tab. 2, trial 4 only DPC) and to compare
the precision in the lower part of the measuring range
Tab. 2 Results from first (trial 1) and second (trial 2 & 3) cients of variation, CV, are given in %.* = Value obtained by ex-
precision experiment. Mean concentrations from 5 runs are given trapolation
in kU/1 except trial 1 with DPC which is based on 10 runs. Coeffi-
Allergen Estimate Pharmacia CAP System
trial 1 trial 2 trial 3
DPC Microplate System









Between run CV (%)
Within run CV (%)
Total CV (%)
Mean cone. kU/1
Between run CV (%)




Within run CV (%)
Total CV (%)
Mean cone. kU/1
Between run CV (%)
Within run CV (%)
Total CV (%)
Mean cone. kU/1
Between run CV (%)
Within run CV (%)
Total CV (%)
Mean cone. kU/1
Between run CV (%)
Within run CV (%)
Total CV (%)
Between run CV (%)























































































































































































Eur J Clin Chem Clin Biochern 1995; 33 (No 5)
Costongs et al.:. Performance characteristics of measurement systems 299
(tab. 2, trial 2, 3) a second investigation was performed
with the Pharmacia CAP System and manually (without
Mark V pipette) with the DPC System. This showed a
similar relation between the systems in terms of coeffi-
cient of variation as in trial 1. In trial two, three and
four, new sets of sera were used, so no correlation be-
tween the trials was possible.
The Mark V instrument might contribute to a general
increase of the imprecision* but random variation of the
size shown by the DPC Microplate System makes test-
ing with single determinations questionable.
Systematic differences
The calibrator range for both methods is 0.35-100 kU/1.
The distribution of results below, within and above the
measurement range with the two methods is given in ta-
ble 3.
' A high number of samples, between 4% and 16% for
j the different species, were reported as above the highest
standard point in the DPC Microplate System. The
reason for this can not be deducted from this experiment
but the high variation, the unpredictable behaviour of
serum samples and the calibrator in the dilution experi-
ments and the need for individual optimisation of the
allergen reagents are probably major contributing
factors.
A first comparison between methods was performed on
a class basis and showed the agreement between nega-
Tab. 3 Distribution of results below, within and above the cali-
brator range (0.35 — 100 kU/1). Shadowed boxes show discrepan-






















































































tive samples. 7% (12 out of 197) of the samples were
positive in the Pharmacia CAP System and negative in
the DPC Microplate System. Out of the positive samples
(n = 155), we observed that 45% were within the same
class. 34% of the positive samples in DPC were within
± 1 class of Pharmacia values, 19% of the positive sam-
ple in DPC within ± 2 classes of Pharmacia values and
2% deviated more than 2 classes from the Pharmacia
value. A connected observation was that the DPC
Microplate System gave lower values than Pharmacia in
the low range and higher values in the high range. This
means that of those results matching (n = 75), 72 results
were found within class 2—4.
Cases with discrepant results in the low range (tab. 3
and fig. 1), i.e. measurable with the Pharmacia CAP
System but not with the DPC Microplate System and
vice versa, were further studied by immunoblotting.
The twelve samples which were Pharmacia positive and
DPC negative had specific IgE values in the range of
0.75-12.1 kU/1, eight of these were still available and
sent to Pharmacia Diagnostics for analysis. In seven of
eight cases presence of allergen specific antibodies
could be demonstrated and optical density of blotting
pattern scanned, see figure 1. The IgE antibodies were
found to represent major as well as minor allergenic
components of house dust mite, cat dander, timothy pol-
len and mugwort pollen (Pharmacia, personal communi-
cation). In the remaining case, serum no. 80, not present
in figure 1, very week staining corresponding to the ma-
jor mugwort allergens could be seen but not recorded
because of limitations of sensitivity in the scanning
equipment. All the cases with positive Pharmacia CAP
System readings were confirmed by the analysis of IgE
antibodies against individual allergenic components.
Two sera, no. 174 and no. 267, resulted in DPC positive
and Pharmacia negative results. IgE antibodies detect-
able in the Western blot procedure were reported for tim-
othy pollen, birch pollen, mugwort pollen and cat epi-
thelia. No immunoblotting figures were included in the
communication (DPC, personal communication).
Quantitative evaluation of systematic differences
For investigation of quantitative agreement between the
methods both plots of y (DPC) versus χ (Pharmacia) and
of y/x (on a logarithmic scale) versus (x + y)/2 are
given in figure 2. The estimated straight lines and coeffi-
cients of correlation for the xy-plots according to Pass-
ing & Bablock are given in table 4. Overall there is a
low correlation between the methods. In order to exam-
ine the disagreement between the methods the sugges-
tions put forward by Nilsson (16) were followed. Only
samples with both results within the calibrator range
Eur J Clin Chem Clin Biochera 1995; 33 (No 5)
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Fig. 1 Detection of allergen specific IgE antibodies by immu- (Arthemisia vulgaris)), house dust mite, cat dander in serum sam-
noblotting with pollen (timothy (Phleum pratense) and mugwort pies with discordant test results. (Pharmacia+/DPC-~)
were included. From the precision experiment, with go
excluded for the DPC Microplate System (above range),
the expected standard deviation of the scatter expressed
in In (concentration) was estimated as 0.22. No indica-
tion of dependence between differences and concentra-
tion level was obtained and the mean difference ex-
pressed in per cent of the result with the Pharmacia CAP
System was calculated. These values and the CSD-val-
ues (the coefficient of sample-related disagreement) are
given in table 5. For all allergens the sample-related dif-
ferences are significant and as can be seen in table 5
the CSD-values are substantially greater than 1.5. This
indicates that the error contribution from sample-related
differences far exceeds the analytical variation presented
in table 2.
Although an xy-plot may indicate a correlation between
the methods, a ratio plot shows that the disagreement is
considerable. From the ratio plot for dl for example, it
is evident that the ratio y/x varies between 10 and 300%.
The sample-related differences are probably caused by
different capabilities of the two test systems to measure
individual mixtures of IgE antibodies against the aller-
genic components of an allergen. Furthermore, as the
observed mean differences of the DPC Microplate Sys-
tem vary between -25% for go and + 110% for e5, dif-
ferences between the allergens also in terms of calibra-
tion can hardly be excluded. On the contrary, it is very
likely that a variable calibration error is introduced in a
system where each individual allergen-reagent lot must
be adjusted to an optimal signal level (DPC) rather than
to allergen excess (Pharmacia).
It is obvious from the study of systematic differences
that several samples with clearly measurable levels of
IgE antibodies remain undetected by the DPC Micro-
plate System. This fact and the observation that many
cases with low to moderate levels show lower levels
with DPC, is in concordance with the sample related
differences between methods discussed above. Insuffi-
Bur J Clin Chem din Biochem 1995; 33 (No- 5)
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the Pharmacia CAP System [kU/q
Fig. 2 Concentration with DPC Microplate System (y) is plotted
against concentration with Pharmacia CAP System (x) in the dia-
Mean of concentrations measured
with both procedures [kU/l]
grams to the left. For results within the measurement range to ratio
y/x is plotted against (x + y)/2 in the diagrams to the right.
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Tab. 5 Comparison of systematic differences. The mean differ-
ences are expressed in per cent of the results with Pharmacia CAP
System. CSD is the quotient between the standard deviation of
sample-related differences and the standard deviation from the total
within run variation.

























Effect of addition of competing IgG antibodies
The values obtained for sera mixed with negative rabbit
serum are referred to as expected values (E) and the
observations of all other mixtures (O) are expressed as
O/E. The mixtures with negative patient serum are used
to check whether dilutions with negative patient and rab-
bit serum respectively can be considered as equivalent.
The obtained values of O/E for these mixtures are in the
range 86-107% for Pharmacia and 85-120% for DPC,
i. e. well within the range of random variation. For the
mixtures with rabbit serum O/E-values are plotted
against percent of rabbit IgG serum in the sample. As
can be seen from figure 4, the Pharmacia CAP System
gives a moderate decrease for increasing amounts of rab-
bit IgG while the effects in the DPC Micrpplate System
are varying and more dramatic. The results may be ex-
plained by the fact that liquid allergens can be aggre-
gated by allergen specific IgG antibodies present in the
serum sample (Personal communication, PDC). the data
also support the observations made in the evaluation of
systematic differences suggesting insufficient allergen
excess in the DPC system.
cient excess of allergen and/or missing allergenic com-
ponents in the DPC system reagents are the most prob-
able causes for such a deviation.
Effect of dilution
The ratios between observed (O) and expected (E) val-
ues for all diluted samples were calculated. Plots of O/E
against dilution give a rather regular pattern for the
Pharmacia CAP System while the DPC Microplate Sys-
tem exhibits more dramatic effects and very irregular
patterns as illustrated in figure 3. Due to the irregular
pattern shown by DPC it is not relevant to fit a model
to the relationship between O/E and dilution and the
results can hardly be summarized numerically in any
meaningful way. Dilution of the calibrator 100 kU/1 also
showed an irregular pattern, which was confirmed in a
repeated experiment. The unpredictable result may, ac-
cording to the manufacturer, be an effect of interference
by auto-anti-IgE, affinity dependent variation in a non-
excess situation or an under representation of rare aller-
genic proteins in the allergen reagent.
Effect of addition ofunspeciflc IgE
All values are below the measuring range, i. e. < 0.35
kU/1. Thus, addition of unspecific IgE up to 3000 kU/1
does not interfere with specific IgE measurements in the
systems under study.
Comparison of calibrators
The results of the DPC calibrators assayed in the Phar-
macia CAP System and the Pharmacia calibrators as-
sayed in the DPC Microplate System are shown in table
6. The table shows the observed concentrations in per-
cent of the assigned (expected) concentrations.
The calibrators are in good agreement, and the diverging
results obtained when measuring with the DPC Micro-
plate System are in accordance with the high variation
seen in the precision study.
User friendliness
The instruments included with the Pharmacia CAP Sys-
tem are MasterCAP, RoboCAP, AütoCAP and Fluoro-
counter 96. The DPC Microplate System includes
MARK 5 Robotic Pipettor, MAX Automated Plate Proc-
essor with a built-in kinetic reader and a computer with
MAX software designed for DPC Microplate System.
These two systems are similar in function and do not
deviate much from a handling point of view, however,
the limitations in DPC MARK V, such as the restriction
to 4 replicates per patient and the limitation of 96 sam-
ples per assay make RoboCAP, where no such limita-
tions exist, a preferable alternative.
One factor we consider negative is the handling of aller-
gens0 in DPC Microplate System. The allergens supplied
in a bottle have to be opened and closed in combination
Eur J Clin Chem Clin Biochem 1995·; 33 (No 5)
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Fig. 3 Results from dilutions of two sera (I and 2) for each allergen with the Pharmacia CAP
System (Ph) and the DPC Microplate System (DPC).
0/E plotted against dilution.
Ο PH : l Ο DPC : l
^ PH:2 o DPC: 2
with each assay, a tedious procedure for a large panel
of allergens.
For DPC IMMULITE, the first results were obtained
after l h 15 minutes, the time for 50 results was 2 h 7
minutes. This shows a theoretical time advantage when
using the system for differential testing but in practice
no advantage in using the DPC IMMULITE AlaTOP for
allergy screening instead of the Pharmacia CAP System
Phadiatop was found,
RoboCAP is the more flexible and easier to operate in-
strument when comparing the two systems or system
combinations, Pharmacia CAP System to DPC Micro-
plate System and IMMULITE, we find Pharmacia CAP
System to be easier to handle as well as to adapt to
sample and information flow in our laboratory.
Conclusions
We found no advantages to the combination of two DPC
systems from a handling and work flow point of view.
Moreover the Pharmacia CAP System is easier to work
with than the DPC Microplate System. Comparing Pha-
diatop and AlaTOP and investigating the specific IgE
antibody assays and their capability to meet our quality
demands and the need of quantitative measurement ex-
pressed by clinicians, we conclude the following:
Eur J Clin Chem Clin Biochcm 1995; 33 (No 5)
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Phadiatop has a slightly higher sensitivity than AlaTOP
either on IMMUL1TE or on D^C Microplate System.
Both tests perform as expected from the literature
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Fig. 4 Effect of increasing amount of rabbit IgG antibodies on
the determination of specific IgE against dl, g6 and t3.
^ Pharmacia CAP System
© DPC Microplate System.
The DPC Microplate System was shown to be less accu-
rate when compared with the Pharmacia CAP System.
This is true for moderate and higher concentrations,
where we found 2.5 times higher CV's. But at concen-
trations below 3.5 kU/1 the DPC Microplate System
shows, in general, higher CV's. The comparison of re-
sults show that the two methods do not, to the full ex-
tent, measure the same antibodies. This can be con-
cluded based on the results of the correlation/regression
(Passing, Bablok) but more clearly based the study of
the sample related disagreement (CSD).
Furthermore DPC failed to detect specific IgE in at least
12 out of 187 patient samples which were in 8 cases
found positive with Pharmacia CAP System and con-
firmed with blotting experiments. In contrary only 2
samples that were positive by DPC Microplate System
and confirmed by blotting were found negative in Phar-
macia CAP System. 35 results out of the 187 patient
samples were above the calibrator range in the DPC
Microplate System. The corresponding figure for the
Pharmacia CAP System was 1 result.
There was no effect when adding non-specific IgE to
serum samples and the comparison of calibrators show
a good agreement. When looking at the addition of com-
peting IgG antibodies we demonstrated a moderate
decrease in binding of specific IgE in Pharmacia CAP
System.
The effect in the DPC Microplate System was more pro-
nounced with large decreases or increases of measured
values even at lower concentrations. The results may
indicate insufficient allergen concentration in the DPC
assay and draw attention to the risk for undesirable com-
plex formation between allergen and antibody in solu-
tion.
Finally we conclude that the Pharmacia CAP System
provides quantitative measurement of allergen specific
IgE antibodies with acceptable analytical variation
(Pooled CV « 10%), whereas the DPC Microplate Sys-
Tab. 6 Observed concentrations of calibrators in percent of the assigned concentrations.
* = value obtained by extrapolation.
DPC calibrators
assayed in Pharmacia CAP System
Concentration (kU/1)
Ο/Ε Χ 100 Pharmacia calibrators Ο/Ε Χ
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tem results in higher variation and unwanted side effects
when diluting and interfering with IgG. There also seem
to be some problems with stability of the specific IgE
test. The data obtained in this study support the state-
ment that allergen excess is needed for accurate mea-
surement of IgE antibodies. Even though the reagent
prices are marginally higher, we prefer the Pharmacia
CAP System for differential as well as specific IgE test-
ing.
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